CP
Caligan Partners LP Other
US US · SEC (Form 4)
Browse the complete record of transactions filed by Caligan Partners LP. Director active across 2 companies, notably Standard Biotools INC.. Aggregated, 9 reports have been logged. Total volume traded: €11.7m. The latest transaction was filed on 13 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations 9 total
€163,224 100,000 shares @ €1.6322 0.017% mcap 6.0% of flow
Common Stock, $0.001 par value per share ("Common Stock")
SEC:0000902664-22-003296:0 · 13 Jun 2022
Ideal exit: 10 Mar 2023 (T+270) €357,174 200,000 shares @ €1.7859 0.036% mcap 13.1% of flow
Common Stock, $0.001 par value per share ("Common Stock")
SEC:0000902664-22-003177:0 · 2 Jun 2022
Ideal exit: 27 Feb 2023 (T+270) €252,615 79,400 shares @ €3.1816 0.0050% mcap 2.8% of flow
Common Stock, $0.001 par value per share ("Common Stock")
SEC:0000902664-22-003105:0 · 25 May 2022
Ideal exit: 19 Feb 2023 (T+270) €339,029 59,700 shares @ €5.6789 0.0067% mcap 3.8% of flow
Common Stock, $0.001 par value per share ("Common Stock")
SEC:0000902664-22-003037:0 · 17 May 2022
Ideal exit: 11 Feb 2023 (T+270) €1m 463,350 shares @ €2.7515 0.13% mcap 46.6% of flow
Common Stock, $0.001 par value per share (Common Stock)
SEC:0000902664-22-002849:0 · 6 May 2022
Ideal exit: 31 Jan 2023 (T+270) €63,060 27,600 shares @ €2.2848 0.0064% mcap 2.3% of flow
Common Stock, $0.001 par value per share ("Common Stock")
SEC:0000902664-22-002740:0 · 28 Apr 2022
Ideal exit: 23 Jan 2023 (T+270) €8m 1,764,705 shares @ €4.7302 0.16% mcap 93.4% of flow
Common Stock, $0.001 par value per share
SEC:0000902664-22-002594:0 · 18 Apr 2022
Ideal exit: 13 Jan 2023 (T+270) €515,860 145,000 shares @ €3.5577 0.052% mcap 18.9% of flow
Common Stock, $0.001 par value per share ("Common Stock")
SEC:0000902664-22-002542:0 · 11 Apr 2022
Ideal exit: 6 Jan 2023 (T+270) €361,951 109,573 shares @ €3.3033 0.037% mcap 13.2% of flow
Common Stock, $0.001 par value per share ("Common Stock")
SEC:0000902664-22-002486:0 · 6 Apr 2022
Ideal exit: 1 Jan 2023 (T+270) About Caligan Partners LP Caligan Partners LP is a director and insider at Standard Biotools INC. and Liquidia Corp.